TrialSignal transduction and targeted therapy2024

Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib/II trial.

Yaxiong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.